Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
Conditions
- Neovascular (Wet) Age-Related Macular Degeneration
Interventions
- DRUG: aflibercept
- DRUG: High-dose aflibercept
Sponsor
Regeneron Pharmaceuticals
Collaborators